Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
The article shows how different indices measure market breadth and why breadth trends matter for identifying trend strength and potential reversals.
27,800 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Ethereum stays near the pivotal $1,500 support as a potential double bottom forms. A breakout above $1,800 could spar...
Vanguard’s $143 billion tech ETF has outpaced the Nasdaq-100 tracker this year, riding a cost advantage and AI-driven...
The head of the Virtual Assets Regulatory Authority warns that the sector’s AI-driven future will advance only as fas...
Three energy-focused ETFs are delivering roughly 7% yields in 2026 while avoiding K-1 tax forms. They promise simpler...
If you missed Nvidia's historic run, you're not out of luck. This article outlines two solid AI-focused winners at di...
As volatility climbs in 2026, a tax-savvy move is drawing attention: converting traditional IRAs to Roth IRAs when va...
Archer Aviation is progressing toward certification and scale, but the road to profitability remains long. This artic...
Thailand's central bank has flagged unusual stablecoin transfers as part of a broader crackdown on the grey economy. ...
Finassets unveils a bold overhaul of its crypto affiliate program, boosting first-year partner earnings and locking i...
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
When a blue-chip stock posts a stunning earnings beat, investors flock to understand what comes next. This guide brea...